No Detail Found!

A Narrative Review on Pharmacokinetic Aspects of Structural Modification in Drug Design and Therapy

Author(s)
Sheikh Abdul Khaliq Faculty of Pharmacy, Hamdard University,Karachi - 74600,Pakistan
Sana Siddiqui Faculty of Pharmacy, Hamdard University,Karachi - 74600,Pakistan
Abstract
Objective: Objective of current narrative review is to mainly evaluate existing and future developments on basis of pharmacokinetic rules for manufacturing of safe and effective therapeutic molecule during drug design and should take possible actions to standardize modifications. Methodology: In order to write a review; literature has been collected from 2000 to 2024. Data synthesized by PRISMA methodology. Grading-ofRecommendation-Assessment-Development-and-Evaluation criteria were employed for establishing the quality of literature. The review demonstrated the pharmacokinetic aspects of structural modification in drug design. Results: Structural modification resulted in enhanced activity of phenothiazine, estradiol, ibuprofen, galeterone and endomorphines; reduction in toxicity of lethambutol and cetrizine; enhancement of drug delivery of diclofenac; increase anti-nitrosating effect of unsaturated fattyacids, penolics and tocopherols from EVOO (Extra Virgin Olive Oil); and derivation of nucleic acid drugs i.e. Nmethyladenosine and peptide nucleic acids. Conclusion: Structural modifications bring safe pharmacokinetic data of many drugs and revolutionize pharmaceuticals to treat many of diseases. In future many drugs based on modification of structure (pro-drugs) will be available for use of patients with efficiency and safety to improve quality of life. There is a dire need of collaboration of academia and industries to provide various experimental settings and disseminate datasets.
Publication Details
Page(s) 229-238
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 2, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Pharmacokinetics, drug design, Structural Modification, Safety, efficiency
References
Nadendla R. Molecular .2023 .Modification-A Strategy in Drug Discovery and Drug Design. Biomedical Journal of Scientific & Technical Research, 52(2) : 43511-22.
Dhudum R,Ganeshpurkar A,Pawar A,Candidates Drug .2024 .Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications. , 3(1) : 148-71.
Myers T. .2021 .Mosby's dictionary of medicine, nursing & health professions. , : 1944-1980.
Li C,Zhang C,Deng R .2019 .Prediction of human pharmacokinetics of antibody-drug conjugates from nonclinical data. Clinical and translational science, 12(5) : 534-44.
Betts A,Keunecke A,van Steeg TJ .2018 .Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: a comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a populationmodeling approach. , 14624(5) : 751-64.
Ruiz-Garcia A,Bermejo M,Moss A,Casabo VG .2008 .Pharmacokinetics in drug discovery. Journal of pharmaceutical sciences, 97(2) : 654-90.
Herrera Carranza J. Manual .2003 .de farmacia clínica y atención farmacéutica. , 1(2) : 87-8.
Hashida M. .2020 .Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview. Advanced drug delivery reviews, 06(1) : 71-82.
Bryant BJ,Knights KM,Rowland A,Darroch S .2019 .Pharmacology for health professionals. , : 156-164.
Siddiqui S,Naqvi GR,Ali H .2021 .Formulation development of directly compressible mebevarine tablets using superdisintegrant: A way to investigate quality atributes, in vitro release kinetics and stability profile. Pakistan Journal of Pharmaceutical Sciences, 34(3) : 915-25.
Choi YH,Han H-K. Nanomedicines YH .2018 .: current status and future perspectives in aspect of drug delivery and pharmacokinetics. Journal of pharmaceutical investigation, 48(1) : 43-60.
Sweetman SC,Martindale C .2020 .Martindale: The complete drug reference. Sweetman SC, : 1692-1778.
Mahmood I. .2021 .Interspecies Scaling of AntibodyDrug Conjugates (ADC) for the Prediction of Human Clearance. Antibodies, 10(1) : 1-13.
Stefano Giordani .2023 .Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols. Journal of Pharmaceutical and Biomedical Analysis, 115751(30) : 1-12.
Ciociola AA,Cohen LB,Kulkarni P .2013 .How drugs are developed and approved by the FDA: current process and future directions. Official journal of the American College of Gastroenterology| ACG, 407(5) : 620-3.
Wang Y,Xing J,Xu Y .2015 .T modelling for rational drug design. Quarterly reviews of biophysics, 48(4) : 488-515.
Ball K,Bruin G,Escandon E .2022 .Special Section on Pharmacokinetics and ADME of Biological Therapeutics-Minireview Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metab Dispos, 50(6) : 858-66.
Li Y,Meng Q,Yang M .2019 .Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B, 10(6) : 1113-44.
Gohel MC,Sarvaiya KG,Mehta NR,Soni CD,Vyas VU,Dave RK .2005 .Assessment of similarity factor using different weighting approaches. Dissolution Technologies, 12(4) : 22-7.
Hughes JD,Blagg J,Price DA .2008 .Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & medicinal chemistry letters, 07(17) : 4872-5.
Sheth TS,Acharya F .2021 .Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model. Journal of Mathematics in Industry, 11(1) : 1-10.
Yuksel N,Kanık AE,Baykara T. .2000 .Comparison of in vitro dissolution profiles by ANOVAbased, model-dependent and-independent methods. International journal of pharmaceutics, 5173(00) : 00554-8.
Goutelle S,Woillard JB,Neely M,Yamada W .2022 .Nonparametric methods in population pharmacokinetics. The Journal of Clinical Pharmacology, 62(2) : 142-57.
Bonate PL .2005 .Recommended reading in population pharmacokinetic pharmacodynamics. The AAPS journal, 7(37) : E363-E73.
Shirke S,Shewale S,Satpute M. PRODRUG,Sciences M. PRODRUG .2015 .DESIGN: AN OVERVIEW. International Journal of Pharmaceutical, 5(1) : 232-41.
Pal A,Banik BK .2020 .Highly Efficient Prodrugs: Design and Therapeutic Applications (AReview). Oriental Journal of Chemistry, 36(6) : 985-1000.
Khaliq SA,Khan M,Azeem S,Fatima A .2024 .A Narrative Review on Current Development and Future Prospects for the Treatment of Dengue Virus Infection. Liaquat National Journal of Primary Care, 6(2) : 165-73.
Lindsey WT,Olin BR,Hansen RA. Systematic,Review RA. Systematic,Meta-Analysis RA. Systematic,Bentley JP,McGraw-Hill Education JP .2020 .. Aparasu RR, 14 : 151-160.
Alonso-Coello P,Schünemann HJ,Moberg J .2016 .GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. Br Med, 353(1) : 01-10.
Deng C,Liu J,Zhang W. Structural .2022 .modification in anesthetic drug development for prodrugs and soft drugs. Frontiers in Pharmacology, 923353(1) : 1-14.
Oyeneyin O,Ipinloju N,Ojo N,Akerele D .2021 .Structural modification of ibuprofen as new NSAIDs via DFT, molecular docking and pharmacokinetics studies. International Journal of Advances in Engineering and Pure Sciences, 33(4) : 614-26.
Roost C,Lynch SR,Batista PJ,Qu K,Chang HY,Kool ET .2015 .Structure and thermodynamics of N6-methyladenosine in RNA: a springloaded base modification. Journal of the American Chemical Society, 137(5) : 2107-15.
Lobo S,Li H,Farhan N,Yan G .2013 .Evaluation of diclofenac prodrugs for enhancing transdermal delivery. Drug development and industrial pharmacy, 76782(3) : 425-32.
Purushottamachar P,Godbole AM,Gediya LK .2013 .Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer. Journal of medicinal chemistry, 56(12) : 4880-98.
Mallareddy JR,Borics A,Keresztes A,Tourwé D,Tóth G .2011 .Design, synthesis, pharmacological evaluation, and structureactivity study of novel endomorphin analogues with multiple structural modifications. Journal of medicinal chemistry, 54(5) : 1462-72.
Chiaberge S,Guglielmetti G,Montanari L .2009 .Investigation of asphaltene chemical structural modification induced by thermal treatments. Energy & fuels, 23(9) : 4486-95.
Lim S-A .2006 .Ethambutol-associated optic neuropathy. Annals-academy of Medicine, 35(4) : 274-8.
Dragulescu-Andrasi A,Rapireddy S,Frezza BM,Gayathri C,Gil RR,Ly DH .2006 .A simple γ- backbone modification preorganizes peptide nucleic acid into a helical structure. Journal of the American Chemical Society, 128(31) : 10258-67.
Napolitano A,Panzella L,Savarese M .2004 .Acid-induced structural modifications of unsaturated fatty acids and phenolic olive oil constituents by nitrite ions: a chemical assessment. , 17(10) : 1329-37.
Baltes E,Coupez R,Giezek H,Voss G,Meyerhoff C .2001 .Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundamental & Clinical Pharmacology, 00035(4) : 8206-77.
Tambe V,Ditani A,Rajpoot K,Tekade RK,Tekade RK,Gijrat RK .2021 .Pharmacokinetics aspects of structural modifications in drug design and therapy. -12-814425- 1, : 00014-0.
Abbas AM,Nasrallah HH,Aboelmagd A,Anti-Inflammatory Activity .2024 .Docking Study of New Ibuprofen Derivatives. International Journal of Molecular Sciences, 25(6) : 1-22.
Sacha M,Faucon L,Hamon E,Ly I .2018 .Ex vivo transdermal absorption of a liposome formulation of diclofenac. Biomedicine & Pharmacotherapy, 12(1) : 785-90.
Korneev D,Pevneva G,Voronetskaya N. .2021 .Effects of the composition and molecular structure of heavy oil asphaltenes on their reactivity in thermal decomposition processes. Petroleum Chemistry, 61(1) : 152-61.
Mishra MK,Kukal S,Paul PR .2021 .Insights into structural modifications of valproic acid and their pharmacological profile. Molecules, 27(1) : 1-19.
Islam S,Hosen MA,Ahmad S .2022 .Synthesis, antimicrobial, anticancer activities, PASS prediction, molecular docking, molecular dynamics and pharmacokinetic studies of designed methyl α-D-glucopyranoside esters. Journal of Molecular Structure, 13276(1) : 1-16.
Song W,Si S. .2017 .The rare ethambutol-induced optic neuropathy: a case-report and literature review. Medicine, 96(2) : 00000000000058-89.
Padilla MN,Mata-Pérez C,Melguizo M .2016 .In vitro nitro-fatty acid release from Cys-NO2-fatty acid adducts under nitrooxidative conditions. Nitric Oxide, 12(1) : 14-22.
Correia A,Monteiro A,Silva R,Moreira J,Lobo JS,Silva A .2022 .Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Advanced Drug Delivery Reviews, 114485(1) : 1-22.
Gao G,Wang Y,Hua H,Li D,Tang C,Biological Activity,Chemistry Synthetic .2021 .. Mar Drugs, 19(7) : 1-30.
0

Citations

0

Downloads

9

Views